These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23052152)

  • 21. Effect of Wujijing Oral Liquid on menstrual disturbance of women.
    Geng SS; Li HZ; Wu XK; Dang JM; Tong H; Zhao CY; Liu Y; Cai YQ
    J Ethnopharmacol; 2010 Apr; 128(3):649-53. PubMed ID: 20051257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrograde amnesia after electroconvulsive therapy: a temporary effect?
    Meeter M; Murre JM; Janssen SM; Birkenhager T; van den Broek WW
    J Affect Disord; 2011 Jul; 132(1-2):216-22. PubMed ID: 21450347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein.
    Palmio J; Huuhka M; Laine S; Huhtala H; Peltola J; Leinonen E; Suhonen J; Keränen T
    Psychiatry Res; 2010 May; 177(1-2):97-100. PubMed ID: 20378182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of electroconvulsive therapy on GABAergic function in major depressive patients.
    Esel E; Kose K; Hacimusalar Y; Ozsoy S; Kula M; Candan Z; Turan T
    J ECT; 2008 Sep; 24(3):224-8. PubMed ID: 18562944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature.
    Li TC; Shiah IS; Sun CJ; Tzang RF; Huang KC; Lee WK
    J ECT; 2011 Jun; 27(2):165-7. PubMed ID: 21602639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prolactin and the menstrual cycle].
    Topalski-Fistes N; Bujas M; Maticki-Sekulić M; Suvacarev S
    Med Pregl; 1999; 52(1-2):39-43. PubMed ID: 10352503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures.
    De Souza MJ; Toombs RJ; Scheid JL; O'Donnell E; West SL; Williams NI
    Hum Reprod; 2010 Feb; 25(2):491-503. PubMed ID: 19945961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum prolactin response to electroconvulsive therapy in patients with major depression].
    Duan Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Oct; 24(5):272-4. PubMed ID: 1752177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulus pulse-frequency-dependent efficacy and cognitive adverse effects of ultrabrief-pulse electroconvulsive therapy in patients with major depression.
    Roepke S; Luborzewski A; Schindler F; Quante A; Anghelescu I; Heuser I; Bajbouj M
    J ECT; 2011 Jun; 27(2):109-13. PubMed ID: 20938351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient postictal psychosis associated with a course of ECT.
    Zwil AS; Pomerantz A
    Convuls Ther; 1997 Mar; 13(1):32-6. PubMed ID: 9152586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sham electroconvulsive therapy studies in depressive illness: a review of the literature and consideration of the placebo phenomenon in electroconvulsive therapy practice.
    Rasmussen KG
    J ECT; 2009 Mar; 25(1):54-9. PubMed ID: 18580816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?
    Rabheru K
    J ECT; 2012 Mar; 28(1):39-47. PubMed ID: 22330700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac rhythm management devices and electroconvulsive therapy: a critical review apropos of a depressed patient with a pacemaker.
    Kokras N; Politis AM; Zervas IM; Pappa D; Markatou M; Katirtzoglou E; Papadimitriou GN
    J ECT; 2011 Sep; 27(3):214-20. PubMed ID: 21206373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory.
    Falconer DW; Cleland J; Fielding S; Reid IC
    Psychol Med; 2010 Jun; 40(6):1017-25. PubMed ID: 19775495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment strategies in major depression: a 2-year prospective naturalistic follow-up after successful electroconvulsive therapy.
    Martínez-Amorós E; Cardoner N; Soria V; Gálvez V; Menchón JM; Urretavizcaya M
    J ECT; 2012 Jun; 28(2):92-7. PubMed ID: 22531201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical examination of bifrontal electroconvulsive therapy: clinical efficacy, cognitive side effects, and directions for future research.
    Crowley K; Pickle J; Dale R; Fattal O
    J ECT; 2008 Dec; 24(4):268-71. PubMed ID: 18648318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substitution of rapid transcranial magnetic stimulation treatments for electroconvulsive therapy treatments in a course of electroconvulsive therapy.
    Pridmore S
    Depress Anxiety; 2000; 12(3):118-23. PubMed ID: 11126185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilateral posterior vitreous detachment after electroconvulsive therapy.
    Martínez-Amorós E; Real Barrero E; Fuste Fusares C; Hernández-Ribas R; Urretavizcaya Sarachaga M
    Gen Hosp Psychiatry; 2009; 31(4):385-7. PubMed ID: 19555802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electroconvulsive therapy-induced migraine successfully treated with valproic acid.
    Rovers JM; Roks G
    J ECT; 2012 Mar; 28(1):64-5. PubMed ID: 22343586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series.
    O'Reardon JP; Takieddine N; Datto CJ; Augoustides JG
    J ECT; 2006 Dec; 22(4):247-52. PubMed ID: 17143155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.